These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 30015109)

  • 21. From Clozapine to Cognitive Remediation.
    Quinn J; Kolla NJ
    Can J Psychiatry; 2017 Feb; 62(2):94-101. PubMed ID: 27335156
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Study on clozapine treatment at the Charles Perrens Hospital in Bordeaux, 15 years after its marketing].
    Mercier C; Bret P; Bret MC; Queuille E
    Encephale; 2009 Sep; 35(4):321-9. PubMed ID: 19748368
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A systematic review of the evidence of clozapine's anti-aggressive effects.
    Frogley C; Taylor D; Dickens G; Picchioni M
    Int J Neuropsychopharmacol; 2012 Oct; 15(9):1351-71. PubMed ID: 22339930
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effect size of symptom status in withdrawal of typical antipsychotics and subsequent clozapine treatment in patients with treatment-resistant schizophrenia.
    Pickar D; Bartko JJ
    Am J Psychiatry; 2003 Jun; 160(6):1133-8. PubMed ID: 12777272
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Outcomes of medicaid beneficiaries with schizophrenia receiving clozapine only or antipsychotic combinations.
    Velligan DI; Carroll C; Lage MJ; Fairman K
    Psychiatr Serv; 2015 Feb; 66(2):127-33. PubMed ID: 25321616
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Predictors of clozapine discontinuation at 2 years in treatment-resistant schizophrenia.
    Iruretagoyena B; Castañeda CP; Mena C; Diaz C; Nachar R; Ramirez-Mahaluf JP; González-Valderrama A; Undurraga J; Maccabe JH; Crossley NA
    Schizophr Res; 2021 Sep; 235():102-108. PubMed ID: 34340062
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Schizophrenia, violence, clozapine and risperidone: a review. The Special Hospitals Treatment Resistant Schizophrenia Research Group.
    Br J Psychiatry Suppl; 1996 Dec; (31):21-30. PubMed ID: 8968652
    [No Abstract]   [Full Text] [Related]  

  • 28. Time course of improvement with antipsychotic medication in treatment-resistant schizophrenia.
    Suzuki T; Remington G; Arenovich T; Uchida H; Agid O; Graff-Guerrero A; Mamo DC
    Br J Psychiatry; 2011 Oct; 199(4):275-80. PubMed ID: 22187729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Augmentation strategies in partial responder and/or treatment-resistant schizophrenia patients treated with clozapine.
    Muscatello MR; Bruno A; De Fazio P; Segura-Garcia C; Pandolfo G; Zoccali R
    Expert Opin Pharmacother; 2014 Nov; 15(16):2329-45. PubMed ID: 25284216
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effect of clozapine and adjunctive high-dose glycine in treatment-resistant schizophrenia.
    Potkin SG; Jin Y; Bunney BG; Costa J; Gulasekaram B
    Am J Psychiatry; 1999 Jan; 156(1):145-7. PubMed ID: 9892314
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Clozapine in schizophrenia and its association with treatment satisfaction and quality of life: Findings of the three national surveys on use of psychotropic medications in China (2002-2012).
    Li Q; Xiang YT; Su YA; Shu L; Yu X; Correll CU; Ungvari GS; Chiu HF; Ma C; Wang GH; Bai PS; Li T; Sun LZ; Shi JG; Chen XS; Mei QY; Li KQ; Si TM; Kane JM
    Schizophr Res; 2015 Oct; 168(1-2):523-9. PubMed ID: 26277534
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A machine learning approach using auditory odd-ball responses to investigate the effect of Clozapine therapy.
    Ravan M; Hasey G; Reilly JP; MacCrimmon D; Khodayari-Rostamabad A
    Clin Neurophysiol; 2015 Apr; 126(4):721-30. PubMed ID: 25213349
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Childhood-onset schizophrenia: A double-blind, randomized clozapine-olanzapine comparison.
    Shaw P; Sporn A; Gogtay N; Overman GP; Greenstein D; Gochman P; Tossell JW; Lenane M; Rapoport JL
    Arch Gen Psychiatry; 2006 Jul; 63(7):721-30. PubMed ID: 16818861
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Term Outcome of Clozapine in Treatment-Resistant Schizophrenia.
    Lee MA; Cola P; Jayathilake K; Meltzer HY
    J Clin Psychopharmacol; 2023 May-Jun 01; 43(3):211-219. PubMed ID: 36975722
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aripiprazole in treatment-refractory schizophrenia.
    Hsu WY; Lee CI; Chiu NY; Kahn DA
    J Psychiatr Pract; 2009 May; 15(3):221-6. PubMed ID: 19461396
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clozapine: a comparison with other novel antipsychotics.
    Fleischhacker WW
    J Clin Psychiatry; 1999; 60 Suppl 12():30-4. PubMed ID: 10372608
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The effects of clozapine on cognitive functioning in schizophrenia.
    McGurk SR
    J Clin Psychiatry; 1999; 60 Suppl 12():24-9. PubMed ID: 10372607
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of clozapine on cognitive function in schizophrenia.
    Lee MA; Thompson PA; Meltzer HY
    J Clin Psychiatry; 1994 Sep; 55 Suppl B():82-7. PubMed ID: 7961582
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association between subjective well-being and depressive symptoms in treatment-resistant schizophrenia before and after treatment with clozapine.
    Kim JH; Lee J; Kim YB; Han AY
    Compr Psychiatry; 2014 Apr; 55(3):708-13. PubMed ID: 24332387
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.